Abbott Laboratories (LON: 0Q15)
London
· Delayed Price · Currency is GBP · Price in USD114.51
+1.23 (1.09%)
At close: Dec 20, 2024
Abbott Laboratories Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 30, 2021 | Dec '20 Dec 30, 2020 | Dec '19 Dec 30, 2019 | 2018 - 2014 |
| Revenue | 41,217 | 40,109 | 43,653 | 43,075 | 34,608 | 31,904 | Upgrade
|
| Revenue Growth (YoY) | 3.15% | -8.12% | 1.34% | 24.47% | 8.48% | 4.34% | Upgrade
|
| Cost of Revenue | 18,174 | 17,919 | 19,083 | 18,080 | 15,003 | 13,231 | Upgrade
|
| Gross Profit | 23,043 | 22,190 | 24,570 | 24,995 | 19,605 | 18,673 | Upgrade
|
| Selling, General & Admin | 10,902 | 10,385 | 10,703 | 11,006 | 9,591 | 9,540 | Upgrade
|
| Research & Development | 2,646 | 2,619 | 2,741 | 2,738 | 2,420 | 2,440 | Upgrade
|
| Operating Expenses | 15,442 | 14,970 | 15,457 | 15,791 | 14,143 | 13,916 | Upgrade
|
| Operating Income | 7,601 | 7,220 | 9,113 | 9,204 | 5,462 | 4,757 | Upgrade
|
| Interest Expense | -582 | -637 | -558 | -533 | -546 | -670 | Upgrade
|
| Interest & Investment Income | 342 | 385 | 183 | 43 | 46 | 94 | Upgrade
|
| Currency Exchange Gain (Loss) | -7 | -41 | -2 | -1 | 8 | -7 | Upgrade
|
| Other Non Operating Income (Expenses) | -69 | -22 | -40 | 7 | 13 | -34 | Upgrade
|
| EBT Excluding Unusual Items | 7,285 | 6,905 | 8,696 | 8,720 | 4,983 | 4,140 | Upgrade
|
| Merger & Restructuring Charges | -204 | -144 | -234 | -509 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -39 | -39 | -45 | - | -115 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -143 | - | - | - | - | - | Upgrade
|
| Asset Writedown | -176 | -100 | -111 | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | 100 | - | Upgrade
|
| Other Unusual Items | 55 | 42 | - | - | - | -63 | Upgrade
|
| Pretax Income | 6,778 | 6,664 | 8,306 | 8,211 | 4,968 | 4,077 | Upgrade
|
| Income Tax Expense | 1,011 | 941 | 1,373 | 1,140 | 497 | 390 | Upgrade
|
| Earnings From Continuing Operations | 5,767 | 5,723 | 6,933 | 7,071 | 4,471 | 3,687 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | 24 | - | Upgrade
|
| Net Income | 5,767 | 5,723 | 6,933 | 7,071 | 4,495 | 3,687 | Upgrade
|
| Preferred Dividends & Other Adjustments | 23 | 22 | 28 | 29 | 22 | 21 | Upgrade
|
| Net Income to Common | 5,744 | 5,701 | 6,905 | 7,042 | 4,473 | 3,666 | Upgrade
|
| Net Income Growth | 11.72% | -17.45% | -1.95% | 57.31% | 21.91% | 55.70% | Upgrade
|
| Shares Outstanding (Basic) | 1,740 | 1,740 | 1,753 | 1,775 | 1,773 | 1,768 | Upgrade
|
| Shares Outstanding (Diluted) | 1,749 | 1,749 | 1,764 | 1,789 | 1,786 | 1,781 | Upgrade
|
| Shares Change (YoY) | -0.12% | -0.85% | -1.40% | 0.17% | 0.28% | 0.62% | Upgrade
|
| EPS (Basic) | 3.30 | 3.28 | 3.94 | 3.97 | 2.52 | 2.07 | Upgrade
|
| EPS (Diluted) | 3.29 | 3.26 | 3.91 | 3.94 | 2.50 | 2.06 | Upgrade
|
| EPS Growth | 12.04% | -16.62% | -0.76% | 57.38% | 21.53% | 54.98% | Upgrade
|
| Free Cash Flow | 6,486 | 5,059 | 7,804 | 8,648 | 5,724 | 4,498 | Upgrade
|
| Free Cash Flow Per Share | 3.71 | 2.89 | 4.42 | 4.83 | 3.20 | 2.53 | Upgrade
|
| Dividend Per Share | 2.200 | 2.080 | 1.920 | 1.820 | 1.530 | 1.320 | Upgrade
|
| Dividend Growth | 7.84% | 8.33% | 5.49% | 18.95% | 15.91% | 13.79% | Upgrade
|
| Gross Margin | 55.91% | 55.32% | 56.28% | 58.03% | 56.65% | 58.53% | Upgrade
|
| Operating Margin | 18.44% | 18.00% | 20.88% | 21.37% | 15.78% | 14.91% | Upgrade
|
| Profit Margin | 13.94% | 14.21% | 15.82% | 16.35% | 12.92% | 11.49% | Upgrade
|
| Free Cash Flow Margin | 15.74% | 12.61% | 17.88% | 20.08% | 16.54% | 14.10% | Upgrade
|
| EBITDA | 10,825 | 10,463 | 12,380 | 12,742 | 8,789 | 7,771 | Upgrade
|
| EBITDA Margin | 26.26% | 26.09% | 28.36% | 29.58% | 25.40% | 24.36% | Upgrade
|
| D&A For EBITDA | 3,224 | 3,243 | 3,267 | 3,538 | 3,327 | 3,014 | Upgrade
|
| EBIT | 7,601 | 7,220 | 9,113 | 9,204 | 5,462 | 4,757 | Upgrade
|
| EBIT Margin | 18.44% | 18.00% | 20.88% | 21.37% | 15.78% | 14.91% | Upgrade
|
| Effective Tax Rate | 14.92% | 14.12% | 16.53% | 13.88% | 10.00% | 9.57% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.